News

Newly founded company of SPARK team MyoPax receives 1.3 million Euro loan

Thank you for participating in our 2022 SPARK-BIH Call and NeuroCure/SPARK Call sessions

Charité neuroscientist Prof. Dr. Surjo Soekadar awarded with ERC Proof of Concept (ERCPoC) grant after NeuroCure/SPARK-BIH funding

EpiBlok Therapeutics GmbH is developing a gene therapy for epilepsy

Denmark's SPARK program has recently been founded at the University of Copenhagen

Dr. Angelika Vlachou, Principal at High-Tech Gründerfonds (HTGF), supported 25 translational SPARK project teams with a dedicated hands-on Pitch Training Workshop.

SPARK-BIH and NeuroCure organized a second Design Thinking workshop.

After the successful implementation of the NeuroCure/SPARK program, NeuroCure and SPARK-BIH prolong their collaboration and will run a second call for projects.

Researchers led by our SPARKee Ulrike Stein of the ECRC and Robert Preißner of Charité report in "Clinical and Translational Medicine" that statins inhibit a gene that promotes cancer cell metastasis.

NeuroCure grants funding extension to the four NeuroCure/SPARK-BIH teams for an additional year.